Agilent Technologies Debt to Equity Ratio 2006-2018 | A

Current and historical debt to equity ratio values for Agilent Technologies (A) over the last 10 years.
Agilent Technologies Annual Debt/Equity Ratio
2017 0.42
2016 0.45
2015 0.40
2014 0.31
2013 0.51
2012 0.46
2011 0.51
2010 1.14
2009 1.16
2008 0.83
2007 0.65
2006 0.41
2005 0.00
Agilent Technologies Quarterly Debt/Equity Ratio
Q2 2018 0.46
Q1 2018 0.47
Q4 2017 0.42
Q3 2017 0.45
Q2 2017 0.47
Q1 2017 0.46
Q4 2016 0.45
Q3 2016 0.43
Q2 2016 0.45
Q1 2016 0.43
Q4 2015 0.40
Q3 2015 0.40
Q2 2015 0.40
Q1 2015 0.39
Q4 2014 0.31
Q3 2014 0.39
Q2 2014 0.48
Q1 2014 0.50
Q4 2013 0.51
Q3 2013 0.56
Q2 2013 0.44
Q1 2013 0.44
Q4 2012 0.46
Q3 2012 0.45
Q2 2012 0.46
Q1 2012 0.49
Q4 2011 0.51
Q3 2011 0.52
Q2 2011 0.54
Q1 2011 0.64
Q4 2010 1.14
Q3 2010 1.31
Q2 2010 1.10
Q1 2010 1.12
Q4 2009 1.16
Q3 2009 0.87
Q2 2009 0.89
Q1 2009 0.86
Q4 2008 0.83
Q3 2008 0.73
Q2 2008 0.75
Q1 2008 0.67
Q4 2007 0.65
Q3 2007 0.46
Q2 2007 0.42
Q1 2007 0.41
Q4 2006 0.41
Q3 2006 0.40
Q2 2006 0.37
Q1 2006 0.36
Q4 2005 0.00
Q3 2005 0.29
Q2 2005 0.30
Q1 2005 0.31
Sector Industry Market Cap Revenue
Computer and Technology Electrical Test Equipment $21.098B $4.472B
Agilent Technologies Inc. focuses its expertise on six key markets: Food; Environmental and Forensics; Pharmaceutical; Diagnostics; Chemical and Energy; and Research. Agilent helps ensure that their global food supply is free of contaminants, whether chemical, viral, bacterial or microbiological. The Company's customers include government regulators and labs that control food safety, as well as private companies that produce, package and sell food to the public. Agilent has one of the broadest solutions portfolios of any company serving the pharmaceutical industry. Its solutions provide precise answers for every segment of the pharmaceutical industry, from disease research and drug discovery to drug development, manufacturing and quality control. Agilent gives doctors a head start in the fight against cancer and other diseases. Agilent's immunohistochemistry (IHC) products provide high staining quality, improved standardization and increased efficiency enabling the ultimate goal of increased patient safety.
Stock Name Country Market Cap PE Ratio
Fortive (FTV) United States $27.691B 24.18
AMETEK (AME) United States $17.545B 25.48
Cognex (CGNX) United States $8.942B 37.13
Teradyne (TER) United States $7.760B 20.40
National Instruments (NATI) United States $5.935B 40.81
Itron (ITRI) United States $2.401B 25.25